Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Wednesday, June 21 • 10:30am - 11:45am
#321: Engagement, Education, Networks, Media, and Societies in Rare Diseases: The MUST Haves

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-543-L04-P; CME 1.25; IACET 1.25; RN 1.25

Patient networks, patient engagement and education is critical to patients' involvement in clinical trials. This plays out through social media and patient networks to disseminate information about opportunities more rapidly through a much broader audience. Due to the limited number of potential subjects , the contribution of multiple medical groups to a given trial necessitates the development of physician/patient networks as an integral part of the recruitment process. Societies are instrumental in disseminating , demystifying and educating patients about clinical trial opportunities which can assist in recruiting, retention and conducting these trials.

Learning Objectives

Describe and discuss communication pathways and approaches between key stakeholders in the development of rare disease therapies

Chair

Scott Douglas Schliebner, MPH

Speaker

A Mutually Beneficial Partnership: Engaging Advocacy and Patient Groups to Assist with Clinical Trial Recruitment
Kelly Franchetti, BSN, RN

Engaging the Rare Disease Patient Voice Through Social Media, Social Listening, and Online Communities
Scott Douglas Schliebner, MPH

Leveraging Referring Physician Networks for Rare Disease Research
Bonnie A. Brescia

Utilizing the Power of Many to Direct the Development of the Few: The Entrepreneurial Scope of the New Generation of Scientists Tasked With Developing Rare Disease Therapies
Dan Tierno, MA, MBA



Moderators
avatar for Scott Schliebner

Scott Schliebner

Vice President, Scientific Affairs, Rare Diseases, PRA Health Sciences
Scott Schliebner is a clinical strategist with a 20+ year background in clinical development specializing in rare diseases and orphan drug development. His experience encompasses all trial phases; a broad variety of study designs; interventional and observational studies; across... Read More →

Speakers
avatar for Bonnie Brescia

Bonnie Brescia

Founding Principal, BBK Worldwide
Bonnie A. Brescia is co-founder of BBK Worldwide, the world leader in patient recruitment and engagement for clinical research and development. An early and consistent voice for patient centricity, Bonnie helped to shape the patient recruitment discipline. Her insights into the w... Read More →
avatar for Kelly Franchetti

Kelly Franchetti

Vice President, Global Head Patient Insights and Engagement, Mapi
Kelly Franchetti, RN, CCRN, CEN, is the Executive Director of Global Patients Insights and Engagement at Mapi. Ms. Franchetti has nearly two decades of direct patient experience gained in hospital and industry settings, including CROs, healthcare technology, patient research, and... Read More →
avatar for Scott Schliebner

Scott Schliebner

Vice President, Scientific Affairs, Rare Diseases, PRA Health Sciences
Scott Schliebner is a clinical strategist with a 20+ year background in clinical development specializing in rare diseases and orphan drug development. His experience encompasses all trial phases; a broad variety of study designs; interventional and observational studies; across... Read More →
avatar for Dan Tierno

Dan Tierno

Strategic Implementation Manager, Bayer
Mr. Dan Tierno has over 20 years of experience in pharmaceutical portfolio management, R&D and commercialization. Mr. Tierno also specializes in digital health initiatives, inclusive of gene editing as well as integration of wearables and big data in clinical trials. Mr. Tierno h... Read More →


Wednesday June 21, 2017 10:30am - 11:45am
S503ab McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616